Navigation Links
IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program
Date:5/15/2008

- Data Presented at the 21st Annual Meeting of The American Society of

Pediatric Hematology/Oncology (ASPHO) Meeting -

IRVINE, Calif., May 15 /PRNewswire-FirstCall/ -- IDM Pharma, Inc. (the Company) (Nasdaq: IDMI) today announced the presentation of updated data from a compassionate access program evaluating mifamurtide (L-MTP-PE) in patients with lung metastases as a result of the progression of osteosarcoma, a rare and often fatal bone tumor that typically affects children and young adults. The data show that L-MTP-PE in combination with other therapies is safe, well- tolerated and exhibited signs of disease control.

The compassionate access program provides L-MTP-PE treatment to patients who have either failed or cannot tolerate treatment with existing therapies compared to the Phase 3 pivotal study, which evaluated newly diagnosed patients.

"The results that we have seen to date from the Phase 3 clinical trial in patients with non-metastatic osteosarcoma are being supported in patients with lung metastases as the L-MTP-PE compassionate access experience continues to be encouraging," said Peter Anderson, M.D., Ph.D., principal investigator and professor of pediatrics, Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center in Houston. "With a formalized protocol now in place, we can address the increasing number of requests for compassionate access to L-MTP-PE and meet the unmet needs of certain patients by providing this much needed treatment option."

Study design and findings

Twenty-nine high-risk osteosarcoma patients (ages 10 - 21) were enrolled and 27 have been treated with L-MTP-PE in the compassionate access program to date (May 8, 2008). Patients in th
'/>"/>

SOURCE IDM Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute
2. Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
3. Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury
4. Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session
5. Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer
8. Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
9. Alseres Pharmaceuticals Enters Agreement to Amend Cethrin(R) License to Lower Milestone Payments and Royalty Rates
10. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
11. Diplomat Specialty Pharmacy Develops and Launches Best-In-Class Electronic Navigator (eNAV(TM)) Patient Care System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 22, 2014 Research and Markets ... Market by Equipment, by Reagent, by Application - Global ... http://photos.prnewswire.com/prnh/20130307/600769 Biopharmaceuticals ... is one of the most important and widely used ... application segment of the cell culture market in 2013. ...
(Date:7/22/2014)... Mass. , July 22, 2014  Decision ... audited multiple sclerosis (MS) patients currently treated ... Tecfidera have ever experienced flushing and/or gastrointestinal ... Tecfidera-treated patients are currently experiencing these side ... the effective medical management of such events. ...
(Date:7/22/2014)... 2014 The number of people overdosing from ... day. Twenty-three percent of the workforce has misused prescription ... and Health, making opioid use a serious threat to ... at the correct dosage with a valid prescription, subtle ... National Safety Council released a guide for ...
Breaking Medicine Technology:Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 3Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 2Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 35 things employers should know about prescription painkiller use 25 things employers should know about prescription painkiller use 3
... Hospital today announced that revolutionary three-dimensional mammography imaging ... patient appointments at the Evergreen Breast Center, which ... Seattle area to offer the breakthrough screening and ... three-dimensional (3-D) digital imaging to create a complete ...
... Prescription drug spending growth slowed from an estimated ... according to new data released today by the Centers ... in Health Affairs. Researchers credit the slowdown in spending ... shifting medication use toward lower cost generic drugs. ...
Cached Medicine Technology:Evergreen Hospital Launches Revolutionary Breast Cancer Detection and Diagnostic Imaging Technology 2Evergreen Hospital Launches Revolutionary Breast Cancer Detection and Diagnostic Imaging Technology 3PCMA: Study Credits PBM Tools with Reducing Prescription Drug Spending Growth 2
(Date:7/22/2014)... City, OK (PRWEB) July 22, 2014 ... the launch of the newest component of its existing ... area hospital within the regional SSM Health Care of ... affiliate health centers that shares its services with an ... primary care centers across several states. As a forward-thinking ...
(Date:7/22/2014)... Provectus has started leading projects ... in addition to working with the long known OS ... as well as the creation of services for other ... requires special gadgets for work, leisure and business. Since ... healthcare, logistics, travelling, sports, education, science and other verticals. ...
(Date:7/22/2014)... 2014 It all started as a meeting ... find common ground. Willem de Liefde wanted to help family, ... lives or careers. , Willem wrote The Ego’s Echo for ... the surface of things. It is an invitation to go ... and commitment. , This book represents a breakthrough in the ...
(Date:7/22/2014)... The market for beauty products in the ... according to new industry reports. Women who seek out ... a new guide published at the Cherry News website. ... at http://cherrynews.com/best-nourishing-eye-serum . , This published guide is ... of the top skin improvement products on the market. ...
(Date:7/22/2014)... 2014 Mona Khan Company today announced ... 15th & 16th, 2014, at the Blanks Studio in ... nationally accredited Bollywood workout was launched in the San ... appealing Bollywood culture, Bombay Jam® is a dance-based total ... and designed with authentic Bollywood flavor. Instructor trainings have ...
Breaking Medicine News(10 mins):Health News:St. Anthony Hospital Expands Its Telemedicine Program with Telepsychiatry 2Health News:St. Anthony Hospital Expands Its Telemedicine Program with Telepsychiatry 3Health News:Provectus Announces Development for Google Glass and Wearables 2Health News:Willem de Liefde, Author and Management Expert, Releases New Guide for Understanding Friends, Family, Co-Workers and Ourselves 2Health News:Eye Serum Review for Women: New Guide Published Online by Top Review Website 2Health News:Mona Khan Company Announces Bombay Jam® Instructor Certification in Los Angeles in August 2014 2Health News:Mona Khan Company Announces Bombay Jam® Instructor Certification in Los Angeles in August 2014 3
... introduces Senator Daschle at his confirmation hearing to be ... WASHINGTON, Jan. 8 Bipartisan Policy Center (BPC) founding ... Health and Human Services Secretary, was introduced by fellow ... confirmation hearing today. The hearing was convened by the ...
... to condemn hurtful comments, study suggests , , THURSDAY, Jan. ... would react to racist acts, a new Canadian study says. ... in Toronto, still chose to partner for an experiment with ... their white peer made racist comments about the black person ...
... for Camp Courage at Mall of AmericaMINNEAPOLIS, Jan. 8 , WHO: ... off their talent in the 3rd annual Dance, ... event will be emceed by Tom ... Participants raise money through pledges to benefit Camp, ...
... in 2009 Continues Growth TrendNORTH HOLLYWOOD, Calif., Jan. 8 ... IPCM ), a leading national hospitalist physician group practice ... practice of Midwest Acute Care Consultants, Inc. (MACC) in ... the St. Louis market, where IPC has established a ...
... The Pew Charitable Trusts announced today that Erik ... safety programs, in its Health & Human Services Policy ... general counsel of the Senate Committee on Environment and ... environmental policy and consumer advocacy to Pew. "We are ...
... Cephalon, Inc . (Nasdaq: CEPH ) ... will present at the J.P. Morgan Healthcare Conference, to ... at approximately 4:00 p.m. Pacific Time (7 p.m. Eastern Time). ... section of the company,s website. The webcast will be archived ...
Cached Medicine News:Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 2Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 3Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 4Health News:Many Turn Blind Eye to Racism 2Health News:Dance With Courage to Benefit Camp Courage 2Health News:IPC The Hospitalist Company Acquires Missouri Practice Group 2Health News:Veteran Environmental Health Expert Erik D. Olson to Join Pew 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 3
... reading card was designed by James Lebensohn, ... near point exercises including words, numbers and ... 20/200, 20/100, 20/65, 20/50, 20/40, 20/30, 20/25, ... in English and metric, Jaeger, point size ...
Standard reading test. Music Bars and Tables...
... The PowerLab 4/25 is an ... suitable for teaching and research use ... animal physiology, pharmacology, neurophysiology, biology, zoology, ... 4/25 supports all ADInstruments signal conditioners ...
9" X 14" translucent plastic may be used with illuminated test cabinet or as a wall chart 20/200 to 20/15....
Medicine Products: